Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL
Barclays PLC reported a 5.32% stake in Zentalis Pharmaceuticals, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 12, 2025
Barclays PLC reported a 5.32% stake in Zentalis Pharmaceuticals, Inc., 3,841,449 shares, as a passive investor on Sep 30, 2025. Filed Nov 12, 2025 (Schedule 13G).
- Stake
- 5.32%
- Shares
- 3,841,449
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Barclays PLC | 5.32% | 3,841,449 |
Source
Related
- Zentalis Pharmaceuticals, Inc.
- Barclays PLC
- Zentalis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Barclays PLC · Aug 13, 2026
- Form 4 · Bruns Ingmar · Oct 1, 2026
- Form 4 · Walters William Thurman · Aug 19, 2026
- Schedule 13G/A · Walters Group · Aug 19, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Form 4 · Johnson David Michael · Jun 18, 2026